GERM

ETF Managers Trust - ETFMG Treatments Testing and Advancements ETF

GERM

$19.15arrow_drop_down0.28%-$0.05

Performance History

Key Stats
Open	$19.28
Prev. Close	$19.21
EPS	-
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	-
PE Ratio	-

	LOW	HIGH
Day Range	19.15	19.28
52 Week Range	15.67	20.19

Ratios
P/B Ratio	-
Revenue	-
Operating M. %	-
Earnings	-
Earnings Growth %	-
EBITDA Margin %	-
ROE %	-
EPS	-

About ETF Managers Trust - ETFMG Treatments Testing and Advancements ETF (GERM)

The ETF Managers Trust - ETFMG Treatments Testing and Advancements ETF (GERM) is an exchange-traded fund that focuses on companies involved in testing and advancements in healthcare treatments. GERM provides investors with exposure to a diverse range of companies that are at the forefront of developing and testing new therapies, drugs, and medical technologies. This ETF offers investors an opportunity to invest in the innovative companies that are driving advancements in the healthcare sector.

One of the key features of GERM is its focus on companies that are actively involved in treatments testing and advancements. This ETF includes companies that are working on breakthrough therapies and drugs for various diseases and medical conditions. By investing in GERM, investors can gain exposure to companies that are working on novel treatment options, potentially offering significant returns in the future.